Incannex Change To Account Receivables from 2010 to 2024

IXHL Stock  USD 1.78  0.04  2.20%   
Incannex Healthcare Change To Account Receivables yearly trend continues to be quite stable with very little volatility. Change To Account Receivables may rise above about -9.3 M this year. From the period between 2010 and 2024, Incannex Healthcare, Change To Account Receivables regression line of its data series had sample variance of 11.4 T and sample variance of 11.4 T. View All Fundamentals
 
Change To Account Receivables  
First Reported
2010-12-31
Previous Quarter
-9.8 M
Current Value
-9.3 M
Quarterly Volatility
3.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.8 K, Interest Expense of 2.6 K or Selling General Administrative of 17.7 M, as well as many indicators such as Price To Sales Ratio of 4.3 K, Dividend Yield of 0.0 or PTB Ratio of 4.46. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
  
Check out the analysis of Incannex Healthcare Correlation against competitors.

Latest Incannex Healthcare's Change To Account Receivables Growth Pattern

Below is the plot of the Change To Account Receivables of Incannex Healthcare Ltd over the last few years. It is Incannex Healthcare's Change To Account Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incannex Healthcare's overall financial position and show how it may be relating to other accounts over time.
Change To Account Receivables10 Years Trend
Slightly volatile
   Change To Account Receivables   
       Timeline  

Incannex Change To Account Receivables Regression Statistics

Arithmetic Mean(1,274,940)
Coefficient Of Variation(265.04)
Mean Deviation2,217,636
Median39,071
Standard Deviation3,379,138
Sample Variance11.4T
Range10M
R-Value(0.60)
Mean Square Error7.9T
R-Squared0.35
Significance0.02
Slope(449,793)
Total Sum of Squares159.9T

Incannex Change To Account Receivables History

2024-9.3 M
2023-9.8 M
2022 7240.0
2021-63.7 K
2020161.1 K
2019-315.5 K
2018-43.7 K

About Incannex Healthcare Financial Statements

Incannex Healthcare investors utilize fundamental indicators, such as Change To Account Receivables, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Account Receivables-9.8 M-9.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out the analysis of Incannex Healthcare Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.36)
Revenue Per Share
0.001
Quarterly Revenue Growth
0.296
Return On Assets
(0.57)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.